Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Performance and clinical evaluation of a sensitive multiplex assay for the rapid detection of common NPM1 mutations.

Hafez M, Ye F, Jackson K, Yang Z, Karp JE, Labourier E, Gocke CD.

J Mol Diagn. 2010 Sep;12(5):629-35. doi: 10.2353/jmoldx.2010.090219.

2.

Novel mutations of the nucleophosmin (NPM-1) gene in Egyptian patients with acute myeloid leukemia: a pilot study.

Kassem N, Hamid AA, Attia T, Baathallah S, Mahmoud S, Moemen E, Safwat E, Khalaf M, Shaker O.

J Egypt Natl Canc Inst. 2011 Jun;23(2):73-8. doi: 10.1016/j.jnci.2011.09.003. Erratum in: J Egypt Natl Canc Inst. 2012 Jun;24(2):105.

3.

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.

Verhaak RG, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W, Uitterlinden AG, Erpelinck CA, Delwel R, Löwenberg B, Valk PJ.

Blood. 2005 Dec 1;106(12):3747-54.

4.

Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification.

Marcinkowska-Swojak M, Handschuh L, Wojciechowski P, Goralski M, Tomaszewski K, Kazmierczak M, Lewandowski K, Komarnicki M, Blazewicz J, Figlerowicz M, Kozlowski P.

Mutat Res. 2016 Apr;786:14-26. doi: 10.1016/j.mrfmmm.2016.02.001.

PMID:
26894557
5.

Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.

Falini B, Nicoletti I, Bolli N, Martelli MP, Liso A, Gorello P, Mandelli F, Mecucci C, Martelli MF.

Haematologica. 2007 Apr;92(4):519-32. Review.

6.

Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia.

Oppliger Leibundgut E, Porret NA, Bienz Muggli M, Baumgartner H, Dahlhaus M, Baerlocher GM.

Ann Hematol. 2013 Jan;92(2):173-7. doi: 10.1007/s00277-012-1617-9.

PMID:
23161387
7.

Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.

Dufour A, Schneider F, Metzeler KH, Hoster E, Schneider S, Zellmeier E, Benthaus T, Sauerland MC, Berdel WE, Büchner T, Wörmann B, Braess J, Hiddemann W, Bohlander SK, Spiekermann K.

J Clin Oncol. 2010 Feb 1;28(4):570-7. doi: 10.1200/JCO.2008.21.6010.

PMID:
20038735
8.

Analysis of NPM1 gene mutations in Chinese adults with acute myeloid leukemia.

Yan L, Chen S, Liang J, Feng Y, Cen J, He J, Chang W, Zhu Z, Pan J, Wu Y, Xue Y, Wu D.

Int J Hematol. 2007 Aug;86(2):143-6.

PMID:
17875528
9.

An allele-specific rt-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia.

Ottone T, Ammatuna E, Lavorgna S, Noguera NI, Buccisano F, Venditti A, Giannì L, Postorino M, Federici G, Amadori S, Lo-Coco F.

J Mol Diagn. 2008 May;10(3):212-6. doi: 10.2353/jmoldx.2008.070166.

10.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Döhner K, Schlenk RF, Habdank M, Scholl C, Rücker FG, Corbacioglu A, Bullinger L, Fröhling S, Döhner H.

Blood. 2005 Dec 1;106(12):3740-6.

11.

Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.

Falini B, Sportoletti P, Martelli MP.

Curr Opin Oncol. 2009 Nov;21(6):573-81. doi: 10.1097/CCO.0b013e3283313dfa. Review.

PMID:
19770764
12.

Is the association of "cup-like" nuclei with mutation of the NPM1 gene in acute myeloid leukemia clinically useful?

Bennett JM, Pryor J, Laughlin TS, Rothberg PG, Burack WR.

Am J Clin Pathol. 2010 Oct;134(4):648-52. doi: 10.1309/AJCPULO8SLW0RKJL.

13.

FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.

Bains A, Luthra R, Medeiros LJ, Zuo Z.

Am J Clin Pathol. 2011 Jan;135(1):62-9. doi: 10.1309/AJCPEI9XU8PYBCIO.

14.

Detection of nucleophosmin 1 mutations by quantitative real-time polymerase chain reaction versus capillary electrophoresis: a comparative study.

Barakat FH, Luthra R, Yin CC, Barkoh BA, Hai S, Jamil W, Bhakta YI, Chen S, Medeiros LJ, Zuo Z.

Arch Pathol Lab Med. 2011 Aug;135(8):994-1000. doi: 10.5858/2010-0490-OAR1.

PMID:
21809990
15.

Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature.

Krstovski N, Tosic N, Janic D, Dokmanovic L, Kuzmanovic M, Spasovski V, Pavlovic S.

Med Oncol. 2010 Sep;27(3):640-5. doi: 10.1007/s12032-009-9261-5. Review.

PMID:
19557552
16.

A new DNA-based test for detection of nucleophosmin exon 12 mutations by capillary electrophoresis.

Szankasi P, Jama M, Bahler DW.

J Mol Diagn. 2008 May;10(3):236-41. doi: 10.2353/jmoldx.2008.070167.

17.

Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).

Falini B, Macijewski K, Weiss T, Bacher U, Schnittger S, Kern W, Kohlmann A, Klein HU, Vignetti M, Piciocchi A, Fazi P, Martelli MP, Vitale A, Pileri S, Miesner M, Santucci A, Haferlach C, Mandelli F, Haferlach T.

Blood. 2010 May 6;115(18):3776-86. doi: 10.1182/blood-2009-08-240457. Erratum in: Blood. 2010 Aug 12;116(6):1017.

18.

C/EBPA gene mutation and C/EBPA promoter hypermethylation in acute myeloid leukemia with normal cytogenetics.

Lu Y, Chen W, Chen W, Stein A, Weiss LM, Huang Q.

Am J Hematol. 2010 Jun;85(6):426-30. doi: 10.1002/ajh.21706.

19.

Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.

Shiseki M, Kitagawa Y, Wang YH, Yoshinaga K, Kondo T, Kuroiwa H, Okada M, Mori N, Motoji T.

Leuk Lymphoma. 2007 Nov;48(11):2141-4.

PMID:
17990177
20.

Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia.

Noguera NI, Ammatuna E, Zangrilli D, Lavorgna S, Divona M, Buccisano F, Amadori S, Mecucci C, Falini B, Lo-Coco F.

Leukemia. 2005 Aug;19(8):1479-82. Erratum in: Leukemia. 2007 May;21(5):1134.

PMID:
15973451
Items per page

Supplemental Content

Support Center